CoronavirusCovid-19Health

AstraZeneca Revises Data on Vaccine Potency Amid Backlash, Says Candidate Still Holds Up

AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data, but maintained that the vaccine provides strong protection against the potentially deadly virus.

The drugmaker said its vaccine showed 76% efficacy against symptomatic disease and 100% against severe disease or the need for hospitalization, CNN reported.

The company also said the vaccine was 85% productive in stopping symptoms in volunteers age 65 and older.

AstraZeneca’s data was made public as a part of a news release, not as a peer review report or an application to the Food and Drug Administration for emergency-use authorization, the company said.

“The primary analysis is consistent with our previously released interim analysis, and confirms that our COVID-19 vaccine is highly effective in adults, including those aged 65 years and over,” said Mene Pangalos, executive vice president for biopharmaceuticals research for AstraZeneca. “We look forward to filing our regulatory submission for emergency use authorization in the U.S. and preparing for the rollout of million of doses across America.”

The numbers aren’t much different from the data AstraZeneca presented Monday, which claimed a 79% efficacy against symptomatic disease and 100% efficacy against severe illness and hospitalization. Those findings drew concerns from an independent monitoring board and the National Institute of Allergy and Infectious Diseases, which said they may have been based on outdated data.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker